BINDER WILLIAM J has a total of 29 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and medical technology are ARBORVITAE HEALTH AND WELLBEING PTY LTD, JANUS PHARMACEUTICALS INC and BIOGEN CHESAPEAKE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Canada | 4 | |
#4 | Australia | 3 | |
#5 | Japan | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | China | 2 | |
#8 | South Africa | 2 | |
#9 | Luxembourg | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Binder William J | 24 |
#2 | William J Binder | 4 |
Publication | Filing date | Title |
---|---|---|
WO2013137969A1 | Treatment of migraine headaches with presynaptic neurotoxin | |
US2013315957A1 | Method of treating vertigo | |
US2013236444A1 | Treatment of migraine headache with diffusion of toxin in non-muscle related foraminal sites | |
JPH10175871A | Treatment of skin lesion involved in skin cytosis | |
EP0845267A1 | Neurotoxins for treating cutaneous disorders in mammals | |
CA2190564A1 | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders | |
ZA9503741B | Method for reduction of headache pain | |
EP1086702A2 | Presynaptic neurotoxins for treatment of migraine headache | |
US4969901A | Plastic surgery implant |